Biosynthetic grape-derived compound prevents progression of Alzheimer’s disease in animal model
Wednesday, May 2, 2012 - 19:30
in Health & Medicine
Researchers have succeeded in developing a biosynthetic polyphenol that improves cognitive function in mice with Alzheimer’s disease (AD). The findings provide insight in determining the feasibility of biosynthetic polyphenols as a possible therapy for AD in humans, a progressive neurodegenerative disease for which there is currently no cure.